US fetal monitoring market boom expected:
This article was originally published in Clinica
US sales of stand-alone fetal monitoring systems and disposable sensors are expected to rise to $69.8 million by 2003, a threefold increase from this year's projected sales of $16.7 million. The introduction of two new technologies - fetal pulse oximetry, which will be used in intrapartum foetal monitors and non-invasive bilirubin screening - will also contribute to the expansion of the $249 million US neonatal/perinatal products market. Non-invasive bilirubin screening is expected to create a $16.3 million US market in the first year of launch (2000) and increase in value to $34.9 million by 2003, reports MedPro Monthly.